Kenya is in working on a new vaccine that will stop new HIV infection in the county.
The Centers for Disease Control Prevention (CDC) is currently working on an HIV vaccine-- HPTN-081, that could put a stop to new infections.
HPTN-081 - is antibody-mediated prevention which will be administered by giving antibodies to individuals to protect them from HIV infections.
Speaking during the 40th anniversary of CDC’s partnership with Kenya in Kisumu on Friday, CDC country director Dr Marc Bulterys said that they are targeting wide roll-out of the vaccine, that will mostly target women.
"We are already done with three trial phases of the vaccine and are working towards making more progress that can help in fully preventing HIV.
“We are focusing on women because they are among the groups with a high risk of being infected,” Dr Bulterys said as quoted by Nation.
Dr Bulterys also said CDC's committee supports the country's Universal Health Coverage (UHC) programme, which part of Kenya’s big four agenda.
“It is our aim to ensure that all groups have access to free quality health care services including the marginalised groups such as gays,” Dr Bulterys said.
US Deputy Chief of Mission Eric Kneedler said that the US government fully supports UHC programme in Kenya.
“The aim is to see Kenya grow from a beneficiary to a benefactor,” Mr Kneedler said.